$7.62-0.20 (-2.56%)
United-Guardian, Inc.
United-Guardian, Inc. in the Consumer Defensive sector is trading at $7.62 with a market capitalization of $32M. The stock is currently 13% below its 52-week high of $8.78, remaining 14.6% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.87M↓ | $2.96M↑ | $2.26M↓ | $2.84M↑ | $2.48M |
| Gross Profit | $1.42M↑ | $1.33M↑ | $953,069↓ | $1.50M↑ | $1.36M |
| Operating Income | $642,449↓ | $721,901↑ | $215,072↓ | $695,453↑ | $610,922 |
| Net Income | $818,902↑ | $649,576↑ | $268,441↓ | $626,826↑ | $560,895 |
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingred...
United-Guardian's rally reflects stronger sales, distribution expansion and recovering cosmetic demand, but valuation and trade risks may limit its near-term appeal.
UG reports higher y/y earnings and sales in Q1, driven by strong demand for Renacidin and increased purchases of cosmetic ingredients.
Philip Morris, Honeywell, Starbucks and United-Guardian highlight Zacks research as growth, innovation and segment strength drive recent performance.
Philip Morris, Honeywell and Starbucks stocks outperform peers as pricing power, aviation demand and turnaround efforts drive growth prospects.
This article walks through three high potential companies and highlights why their cleaner capital structures may appeal to investors watching todayʼs macro and market crosscurrents.